- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04426981
Behavioral Activation in Orthopaedic Trauma Patients: A Pilot Study
January 26, 2022 updated by: Ida Leah Gitajn, Dartmouth-Hitchcock Medical Center
This is a prospective observational pilot study designed to evaluate feasibility and acceptability as well as preliminary efficacy of a behavioral activation intervention among orthopaedic trauma patients after discharge home following their injury.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective observational pilot study designed to evaluate feasibility and acceptability as well as preliminary efficacy of a behavioral activation intervention among orthopaedic trauma patients after discharge home following their injury.
Behavioral activation is a behavioral treatment that focuses on helping participants engage in more rewarding and enjoyable activities.
In the first session, participants will begin to identify domains of their life which are important to them.
In the second session, participants will be assisted in creating an action plan to engage in more activities in one or more domains of importance.
In session 3-8, participants will be assisted in problem solving any challenges they encountered in implementing their previous action plan and will develop a new action plan.
The intervention will continue until participants achieved three action plans or reach the eight-session limit, whichever comes first.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03766
- Dartmouth Hitchcock Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 18 years or older
- Presenting at initial (approximately 2-week) postoperative follow-up
- Prior management of isolated fracture or multi-trauma
Exclusion Criteria:
- Incarceration
- Problems, in the judgement of study personnel, with maintaining follow-up
- Cognitive disability (either acute or chronic)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention arm
Consenting patients will be enrolled into a Behavioral Activation treatment arm.
Behavioral activation is a behavioral treatment that focuses on helping participants engage in more rewarding and enjoyable activities.
|
Behavioral activation is a behavioral treatment that focuses on helping participants engage in more rewarding and enjoyable activities.
In the first session, participants will begin to identify domains of their life which are important to them.
In the second session, participants will be assisted in creating an action plan to engage in more activities in one or more domains of importance.
In session 3-8, participants will be assisted in problem solving any challenges they encountered in implementing their previous action plan and will develop a new action plan.
The intervention will continue until participants achieved three action plans or reach the eight-session limit, whichever comes first.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of patients who agree to enroll
Time Frame: 6 months
|
Feasibility will be assessed based on percentage of patients who agree to enroll sessions
|
6 months
|
|
Score on Modified Treatment Evaluation Inventory Short Form
Time Frame: 6 months
|
Acceptability will be measured qualitatively and using the Modified Treatment Evaluation Inventory Short Form
|
6 months
|
|
Percentage of patients who complete 5 out of 8 possible Behavioral Activation sessions
Time Frame: 6 months
|
Feasibility will be assessed based on patients who complete 5 out of 8 possible Behavioral Activation Sessions
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Score on PROMIS general health survey (Response range is 0 to 100 where 100 indicates better function)
Time Frame: 6 months
|
Preliminary efficacy on functional outcome will be assessed using patient reported functional outcome using PROMIS general health survey
|
6 months
|
|
Score on VAS pain score (Response range is from 0 to 10 where 10 indicates greater pain)
Time Frame: 6 months
|
Pain-related preliminary efficacy will be assessed using patient reported VAS pain score will be assessed
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 9, 2020
Primary Completion (ACTUAL)
September 3, 2021
Study Completion (ACTUAL)
September 3, 2021
Study Registration Dates
First Submitted
June 9, 2020
First Submitted That Met QC Criteria
June 9, 2020
First Posted (ACTUAL)
June 11, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 27, 2022
Last Update Submitted That Met QC Criteria
January 26, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D20133
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures, Bone
-
Jen-Chieh LaiCompleted
-
Shahid Beheshti University of Medical SciencesRecruiting
-
Lawson Health Research InstituteCompleted
-
Artur Salgado SANAMSARecruitingBone Loss | Bone Fractures | Bone Defects | Bone GraftPortugal
-
AO Innovation Translation CenterActive, not recruitingLong Bone FracturesCanada, United States, Australia, Croatia, Chile, Spain, Venezuela, Ghana, Pakistan, Germany, India, Greece
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingFractures | Bone Density | Bone HealthUnited States
-
University Hospital, Clermont-FerrandTerminated
-
IlluminOss Medical, Inc.CompletedHumerus Fracture Metastatic Bone DiseaseUnited States
-
University of UtahCompletedBone Strength | Stress Fractures | Bone Geometry | Biomechanical ChangesUnited States
-
Centre Hospitalier Universitaire Saint PierreRecruiting
Clinical Trials on Behavioral Activation
-
New York State Psychiatric InstituteCallen-Lorde Community Health CenterCompletedHIV Infection | FatigueUnited States
-
Medical University of South CarolinaNot yet recruiting
-
Medical University of South CarolinaNational Cancer Institute (NCI)Recruiting
-
Stanford UniversityCompletedDepression | Major Depressive Disorder | MDDUnited States
-
Hospital Miguel ServetCompletedMajor Depressive DisorderSpain
-
University of WashingtonNational Institute of Mental Health (NIMH)Completed
-
Central Arkansas Veterans Healthcare SystemNational Center for PTSDWithdrawn
-
Stanford UniversityCompletedDepression | Major Depressive Disorder | MDDUnited States
-
Seinajoki Central HospitalTampere UniversityCompletedAnxiety Disorders | Major Depression | Dual Diagnosis | Substance Related DisordersFinland
-
University of WashingtonNational Institute of Mental Health (NIMH); University of South Florida; Weill...Recruiting